 | • レポートコード：QFJ1-4035 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、結腸がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・結腸がん分子診断の市場動向 ・企業の競争状況、市場シェア ・結腸がん分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・結腸がん分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究所） ・結腸がん分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・結腸がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・結腸がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・結腸がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・結腸がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Kingmed、Geneis、Unitedgene、Yin Feng Gene、Inmedi、ApexHealth、Amoydx、Genetronhealth、Berryoncology、Topgen、Roche、Qiagen） ・結論 |
A molecular approach for diagnosing colon cancer
Market Analysis and Insights: Global Colon Cancer Molecular Diagnostics Market
The global Colon Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colon Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colon Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colon Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colon Cancer Molecular Diagnostics market.
Global Colon Cancer Molecular Diagnostics Scope and Market Size
Colon Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Colon Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Kingmed
Geneis
Unitedgene
Yin Feng Gene
Inmedi
ApexHealth
Amoydx
Genetronhealth
Berryoncology
Topgen
Roche
Qiagen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colon Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Colon Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Colon Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Colon Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Colon Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Colon Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Colon Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Colon Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Colon Cancer Molecular Diagnostics Market Trends
2.3.2 Colon Cancer Molecular Diagnostics Market Drivers
2.3.3 Colon Cancer Molecular Diagnostics Market Challenges
2.3.4 Colon Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colon Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Colon Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Colon Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Colon Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Colon Cancer Molecular Diagnostics Revenue
3.4 Global Colon Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Colon Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colon Cancer Molecular Diagnostics Revenue in 2020
3.5 Colon Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Colon Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Colon Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colon Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Colon Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)
5 Colon Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Colon Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Colon Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Colon Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Colon Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Colon Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Colon Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Colon Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Colon Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Colon Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Colon Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Colon Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Colon Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Colon Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Colon Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Colon Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Colon Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Colon Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Colon Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Colon Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Colon Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Colon Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Colon Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Colon Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Colon Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Colon Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Colon Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Colon Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Colon Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Colon Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Colon Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Colon Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Colon Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Colon Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Colon Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Colon Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Colon Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Colon Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Kingmed
11.1.1 Kingmed Company Details
11.1.2 Kingmed Business Overview
11.1.3 Kingmed Colon Cancer Molecular Diagnostics Introduction
11.1.4 Kingmed Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Kingmed Recent Development
11.2 Geneis
11.2.1 Geneis Company Details
11.2.2 Geneis Business Overview
11.2.3 Geneis Colon Cancer Molecular Diagnostics Introduction
11.2.4 Geneis Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Geneis Recent Development
11.3 Unitedgene
11.3.1 Unitedgene Company Details
11.3.2 Unitedgene Business Overview
11.3.3 Unitedgene Colon Cancer Molecular Diagnostics Introduction
11.3.4 Unitedgene Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Unitedgene Recent Development
11.4 Yin Feng Gene
11.4.1 Yin Feng Gene Company Details
11.4.2 Yin Feng Gene Business Overview
11.4.3 Yin Feng Gene Colon Cancer Molecular Diagnostics Introduction
11.4.4 Yin Feng Gene Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Yin Feng Gene Recent Development
11.5 Inmedi
11.5.1 Inmedi Company Details
11.5.2 Inmedi Business Overview
11.5.3 Inmedi Colon Cancer Molecular Diagnostics Introduction
11.5.4 Inmedi Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Inmedi Recent Development
11.6 ApexHealth
11.6.1 ApexHealth Company Details
11.6.2 ApexHealth Business Overview
11.6.3 ApexHealth Colon Cancer Molecular Diagnostics Introduction
11.6.4 ApexHealth Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 ApexHealth Recent Development
11.7 Amoydx
11.7.1 Amoydx Company Details
11.7.2 Amoydx Business Overview
11.7.3 Amoydx Colon Cancer Molecular Diagnostics Introduction
11.7.4 Amoydx Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Amoydx Recent Development
11.8 Genetronhealth
11.8.1 Genetronhealth Company Details
11.8.2 Genetronhealth Business Overview
11.8.3 Genetronhealth Colon Cancer Molecular Diagnostics Introduction
11.8.4 Genetronhealth Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Genetronhealth Recent Development
11.9 Berryoncology
11.9.1 Berryoncology Company Details
11.9.2 Berryoncology Business Overview
11.9.3 Berryoncology Colon Cancer Molecular Diagnostics Introduction
11.9.4 Berryoncology Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Berryoncology Recent Development
11.10 Topgen
11.10.1 Topgen Company Details
11.10.2 Topgen Business Overview
11.10.3 Topgen Colon Cancer Molecular Diagnostics Introduction
11.10.4 Topgen Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 Topgen Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Colon Cancer Molecular Diagnostics Introduction
11.11.4 Roche Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.11.5 Roche Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Details
11.12.2 Qiagen Business Overview
11.12.3 Qiagen Colon Cancer Molecular Diagnostics Introduction
11.12.4 Qiagen Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021)
11.12.5 Qiagen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Colon Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Colon Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Colon Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Colon Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Colon Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Colon Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Colon Cancer Molecular Diagnostics Market Trends
Table 13. Colon Cancer Molecular Diagnostics Market Drivers
Table 14. Colon Cancer Molecular Diagnostics Market Challenges
Table 15. Colon Cancer Molecular Diagnostics Market Restraints
Table 16. Global Colon Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Colon Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Colon Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colon Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Colon Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Colon Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Colon Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Colon Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Colon Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Colon Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Colon Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Colon Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Colon Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Colon Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Colon Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Colon Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Colon Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Colon Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Colon Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Colon Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Colon Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Colon Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Colon Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Colon Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Colon Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Colon Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Colon Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Colon Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Kingmed Company Details
Table 64. Kingmed Business Overview
Table 65. Kingmed Colon Cancer Molecular Diagnostics Product
Table 66. Kingmed Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Kingmed Recent Development
Table 68. Geneis Company Details
Table 69. Geneis Business Overview
Table 70. Geneis Colon Cancer Molecular Diagnostics Product
Table 71. Geneis Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Geneis Recent Development
Table 73. Unitedgene Company Details
Table 74. Unitedgene Business Overview
Table 75. Unitedgene Colon Cancer Molecular Diagnostics Product
Table 76. Unitedgene Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Unitedgene Recent Development
Table 78. Yin Feng Gene Company Details
Table 79. Yin Feng Gene Business Overview
Table 80. Yin Feng Gene Colon Cancer Molecular Diagnostics Product
Table 81. Yin Feng Gene Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Yin Feng Gene Recent Development
Table 83. Inmedi Company Details
Table 84. Inmedi Business Overview
Table 85. Inmedi Colon Cancer Molecular Diagnostics Product
Table 86. Inmedi Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Inmedi Recent Development
Table 88. ApexHealth Company Details
Table 89. ApexHealth Business Overview
Table 90. ApexHealth Colon Cancer Molecular Diagnostics Product
Table 91. ApexHealth Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. ApexHealth Recent Development
Table 93. Amoydx Company Details
Table 94. Amoydx Business Overview
Table 95. Amoydx Colon Cancer Molecular Diagnostics Product
Table 96. Amoydx Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Amoydx Recent Development
Table 98. Genetronhealth Company Details
Table 99. Genetronhealth Business Overview
Table 100. Genetronhealth Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Genetronhealth Recent Development
Table 102. Berryoncology Company Details
Table 103. Berryoncology Business Overview
Table 104. Berryoncology Colon Cancer Molecular Diagnostics Product
Table 105. Berryoncology Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Berryoncology Recent Development
Table 107. Topgen Company Details
Table 108. Topgen Business Overview
Table 109. Topgen Colon Cancer Molecular Diagnostics Product
Table 110. Topgen Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Topgen Recent Development
Table 112. Roche Company Details
Table 113. Roche Business Overview
Table 114. Roche Colon Cancer Molecular Diagnostics Product
Table 115. Roche Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 116. Roche Recent Development
Table 117. Qiagen Company Details
Table 118. Qiagen Business Overview
Table 119. Qiagen Colon Cancer Molecular Diagnostics Product
Table 120. Qiagen Revenue in Colon Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 121. Qiagen Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colon Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Colon Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Colon Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Colon Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Colon Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Colon Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Colon Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Colon Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Colon Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colon Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Colon Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Colon Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Colon Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Colon Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Colon Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Colon Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Colon Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Colon Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Colon Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Colon Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Colon Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Colon Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Colon Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Colon Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Colon Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Colon Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Colon Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Kingmed Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Geneis Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Unitedgene Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Yin Feng Gene Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Inmedi Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. ApexHealth Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Amoydx Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Genetronhealth Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. Berryoncology Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Topgen Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 70. Qiagen Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing pancreatic cancer Market Analysis and Insights: Global Pancreatic Cancer Molecular Diagnostics Market The global Pancreatic Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …- 世界の甲状腺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing thyroid cancer Market Analysis and Insights: Global Thyroid Cancer Molecular Diagnostics Market The global Thyroid Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
- 世界の肝がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing liver cancer Market Analysis and Insights: Global Liver Cancer Molecular Diagnostics Market The global Liver Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With…
- 世界の非侵襲的大腸がんスクリーニング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non Invasive Colon Cancer Screening Market The global Non Invasive Colon Cancer Screening market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
- 世界の肺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing lung cancer Market Analysis and Insights: Global Lung Cancer Molecular Diagnostics Market The global Lung Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…